Thermo Fisher to Invest $2 Billion in U.S. Amid Profit Cut Tied to China Trade War

• Thermo Fisher Scientific will invest $2 billion in the United States over the next four years, including $1.5 billion in manufacturing and $500 million in R&D.

• The company cut its annual profit forecast, in anticipation of the US-China tariff war and proposed cuts to academic research funding, estimating a $400 million hit this year to its sales in China

Thermo Fisher Scientific Inc., a major global player in the life sciences sector, has announced plans to invest $2 billion in its U.S. operations over the next four years. The investment is aimed at bolstering American innovation, enhancing manufacturing capacity, and strengthening the country’s life sciences supply chain.

The investment includes $1.5 billion in capital expenditures to expand and upgrade manufacturing facilities across the United States. An additional $500 million will go toward research and development, focusing on high-impact scientific innovation. The company said the initiative will create high-paying jobs and support U.S. competitiveness in life sciences.

Meanwhile, Thermo Fisher has cut its annual profit forecast, in anticipation of a potential hit from the U.S. and China tariff war and the Trump administration’s proposed cuts to academic research funding.
The company estimates a $400 million hit this year to its sales in China, which represents about 8% of Thermo Fisher’s business.

As of today, Thermo Fisher operates 64 manufacturing sites across 37 U.S. states, producing analytical instruments, diagnostics, and life sciences products. It also offers contract development and manufacturing (CDMO) services to pharmaceutical firms. This expansion builds on a strong existing base in American manufacturing and innovation.

“Thermo Fisher’s commitment to U.S. manufacturing reflects our confidence that America will continue to lead the world in science and innovation,” said Marc N. Casper, chairman, president and CEO of Thermo Fisher Scientific.

Thermo Fisher has more than doubled its U.S. revenue and workforce since 2017, growing from $21 billion to $43 billion in revenue and increasing employee numbers from 28,000 to over 50,000. With the new investment, the company aims to further deepen its impact on the U.S. economy and healthcare infrastructure.